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MEASURING CLINICAL DIFFERENCE
Guidance on minimally important clinical difference
and trial size is needed
Jonathan A Cook methodologist 1, Craig R Ramsay programme director 1, Luke D Vale professor of
health economics 2, On behalf of the DELTA project group
1Health Services Research Unit, University of Aberdeen, Aberdeen AB25 2ZD, UK; 2Institute for Health and Society, Newcastle University, Newcastle
upon Tyne NE2 4AX, UK
The authors of a randomised controlled trial that compared
surgical intervention with rehabilitation in patients with chronic
low back pain reported a statistically significant difference of
less than 10 points in the Oswestry disability index between
groups.1 They concluded that it “did not clearly exceed the
pre-specified minimally important clinical difference,” the value
used in the sample size calculation. It is important to note that
the use of a value in the sample size calculation does not make
it the minimally important clinical difference, as acknowledged
by the authors. The 10 points difference was not justified other
than to reference another trial,2 which itself provided no
justification. We support the view that the reporting of how
sample size is determined requires greater clarity and
transparency and acknowledgment of the discussion that takes
place during trial design.3
Clear guidance is needed on robust methods to determine what
an important difference is and what trial size is needed. The
different requirements of commissioners of trials, reviewers of
grant applications and reports of trial results, and consumers of
research need to be recognised.
The Difference ELicitation in TriAls (DELTA) project is
investigating methods for determining the target difference.4
The project includes a systematic review of methods, a survey
of current trial practice, and development of a guidance
document. We hope this project will facilitate discussion in the
trial community and improve this vital, yet neglected, aspect of
trial design.
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